Renephra

Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal. The company aims to address significant issues of fluid overload and chronic edema/lymphedema in the fields of vascular diseases, oncology, and other conditions. This represents a substantial patient population with unmet clinical needs, and the global market is estimated to be worth £1 billion. Renephra has already achieved proof-of-concept in humans and is now raising £400,000 to conduct device development research and feasibility design.